RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer
Abstract Background Resistance to paclitaxel‐based chemotherapy is the major obstacle in triple‐negative breast cancer (TNBC) treatment. However, overcoming paclitaxel resistance remains an unsolved problem. The present study aimed to determine whether paclitaxel treatment impairs Aly/REF export fac...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
格式: | Article |
語言: | English |
出版: |
Wiley
2025-02-01
|
叢編: | Clinical and Translational Medicine |
主題: | |
在線閱讀: | https://doi.org/10.1002/ctm2.70203 |